

Company Case Study | The Role of Protein in Supporting Metabolic Health in the GLP-1 Era
Information
This session will be recorded on site and will be made available for on-demand viewing from 8th December 2025 till 16th January 2026.
GLP-1 anti-obesity medications have disrupted the health and nutrition landscape globally, reshaping how consumers and industry approach metabolic health. In this session, we will explore how protein has taken centre stage in this evolving conversation—both as a nutrient with critical physiological roles and as a driver of consumer choice.
Drawing on consumer insights, brand case studies, and the science behind protein as a metabolic powerhouse, we will spotlight opportunities for innovation in formulation and product development — and reveal why protein is set to play a pivotal role in the GLP-1 era.
By viewing this session, the sponsor may contact you with product and service information. You can unsubscribe or contact the sender anytime. See the Privacy Policy (https://privacy.informa.com/policies/en/) for details.


